BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25594893)

  • 1. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
    Veeraraghavan S; Viswanadha S; Thappali S; Govindarajulu B; Vakkalanka S; Rangasamy M
    J Pharm Biomed Anal; 2015 Mar; 107():151-8. PubMed ID: 25594893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
    Veeraraghavan S; Thappali S; Viswanadha S; Chennupati S; Nalla S; Golla M; Vakkalanka S; Rangasamy M
    J Pharm Biomed Anal; 2014 Jun; 94():125-31. PubMed ID: 24561338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Quantification of Baricitinib and Methotrexate in Rat Plasma by LC-MS/MS: Application to a Pharmacokinetic Study.
    Veeraraghavan S; Thappali SR; Viswanadha S; Vakkalanka S; Rangaswamy M
    Sci Pharm; 2016; 84(2):347-59. PubMed ID: 27222609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid.
    Beauvais D; Goossens JF; Boyle E; Allal B; Lafont T; Chatelut E; Herbaux C; Morschhauser F; Genay S; Odou P; Danel C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():158-166. PubMed ID: 30029202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry.
    Veeraraghavan S; Thappali S; Viswanadha S; Nalla S; Chennupati S; Golla M; Vakkalanka S; Rangasamy M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 949-950():63-9. PubMed ID: 24463402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC-MS/MS to support a bioequivalence study.
    Sharma P; Patel DP; Sanyal M; Berawala H; Guttikar S; Shrivastav PS
    J Pharm Biomed Anal; 2013 Oct; 84():244-55. PubMed ID: 23867086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline.
    Sun S; Cheng D; Kong S; Li X; Li T; Yu Q; Wang L
    Biomed Chromatogr; 2020 Jan; 34(1):e4703. PubMed ID: 31629393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated LC-MS/MS method for the simultaneous determination of thalidomide and its two metabolites in human plasma: Application to a pharmacokinetic assay.
    Jiang F; Peng X; Cai D; Wen D; Liu Y; Zhi M; Chen J; Hu P; Wang X; Gao Y; Huang M; Gao X; Zhong G
    Biomed Chromatogr; 2018 Aug; 32(8):e4240. PubMed ID: 29529709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated Chiral LC-ESI-MS/MS Method for the Simultaneous Quantification of Darolutamide Diastereomers and Its Active Metabolite in Mice Plasma: Application to a Pharmacokinetic Study.
    Balaji N; Sulochana SP; Saini NK; A SK; Mullangi R
    Drug Res (Stuttg); 2018 Nov; 68(11):615-624. PubMed ID: 29558780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantitation of IC87114, roflumilast and its active metabolite roflumilast N-oxide in plasma by LC-MS/MS: application for a pharmacokinetic study.
    Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Mukkanti K
    J Mass Spectrom; 2012 Dec; 47(12):1612-9. PubMed ID: 23280750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalytical method development, validation and quantification of dorsomorphin in rat plasma by LC-MS/MS.
    Karthikeyan K; Mahat MY; Chandrasekaran S; Gopal K; Franklin PX; Sivakumar BJ; Singh G; Narayanan S; Gopalan B; Khan AA
    Biomed Chromatogr; 2013 Aug; 27(8):1018-26. PubMed ID: 23526253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of evobrutinib and its metabolite evobrutinib-diol in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Yang J; Yu H; Tang Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4575. PubMed ID: 31069837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.
    Rood JJM; van Hoppe S; Schinkel AH; Schellens JHM; Beijnen JH; Sparidans RW
    J Pharm Biomed Anal; 2016 Jan; 118():123-131. PubMed ID: 26540627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
    Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
    J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of thalidomide, lenalidomide and pomadomide in plasma by LC-MS/MS.
    Wang B; Qiang W; Yi J; Gao S; Meng B; Mu Y; Wang B; Wang Z; Tao X
    J Pharmacol Toxicol Methods; 2023; 120():107250. PubMed ID: 36627002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validated UPLC-MS/MS assay using negative ionization mode for high-throughput determination of pomalidomide in rat plasma.
    Iqbal M; Ezzeldin E; Al-Rashood KA; Shakeel F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():76-82. PubMed ID: 25621435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput salting-out assisted liquid-liquid extraction using a 3D printed device and its application in the quantification of ibrutinib and its metabolite PCI-45227 in human serum.
    Écsiová D; Šimkovič M; Uher M; Hroch M
    J Pharm Biomed Anal; 2022 Sep; 219():114923. PubMed ID: 35830774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
    Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
    Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of naringenin on the pharmacokinetics of ibrutinib in rat: A drug-drug interaction study.
    Liu J; Liu H; Zeng Q
    Biomed Chromatogr; 2019 May; 33(5):e4507. PubMed ID: 30754071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study.
    Mangla B; Alam O; Rub RA; Iqbal M; Singh A; Patel KS; Kohli K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122260. PubMed ID: 32679526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.